Model
Edge
Revance Therapeutics Inc.
0001678984
Filing type
4
Filing date
Feb 4, 2025
Updated
Feb 5, 2025 ยท 5:53 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership